Interviews

Donna M. Smith, PharmD, director of clinical affairs at Avella Specialty Pharmacy discusses strategies for the management of new lung cancer treatment options.

From optimizing inhaler technique in patients with chronic obstructive pulmonary disease, to catching red flags when dispensing controlled substances to patients with chronic pain, pharmacists can improve patient outcomes in an evolving treatment landscape.

Michael R. Hess, attorney with Bass Berry & Sims and outside general counsel to many of the largest independent specialty pharmacy companies, discusses adherence trends specialty pharmacies need to be aware of.